Novavax Cash from Operations Quarterly:
-4.09M for Dec. 31, 2012Novavax Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -4.09M |
| Sept. 30, 2012 | -3.793M |
| June 30, 2012 | -6.126M |
| March 31, 2012 | -4.22M |
| Dec. 31, 2011 | -2.869M |
| Sept. 30, 2011 | -3.321M |
| June 30, 2011 | -8.398M |
| March 31, 2011 | -9.041M |
| Dec. 31, 2010 | -5.808M |
| Sept. 30, 2010 | -8.317M |
| June 30, 2010 | -9.347M |
| March 31, 2010 | -9.38M |
| Dec. 31, 2009 | -12.39M |
| Sept. 30, 2009 | -6.417M |
| June 30, 2009 | -7.30M |
| March 31, 2009 | -6.727M |
| Dec. 31, 2008 | -6.72M |
| Sept. 30, 2008 | -10.42M |
| June 30, 2008 | -1.97M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
NVAX Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Sinovac Biotech | 8.183M |
| Biocryst Pharmaceuticals | |
| Hemispherx Biopharma | -4.955M |
NVAX Cash from Operations Quarterly Rankings
| Overall |
50th percentile 3729 of 7590 |
| Sector |
39th percentile 394 of 651 in Healthcare |
| Industry |
57th percentile 102 of 238 in Biotechnology |
NVAX Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -12.39M | Dec 2009 |
| Maximum | -1.970M | Jun 2008 |
| Average | -6.666M |
